Phosphoric Acid Monododecyl Ester

Phosphoric Acid Monododecyl Ester

SCHEMBL3470168

CCCCCCCCCCCCOP(=O)(O)O.OCCN(CCO)CCO.OCCN(CCO)CCO

nearest known ligand 0.72

Full drug profile on Sugi Atlas →

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
LPAR3 Q9UBY5 13/20 0.72
LPAR2 Q9HBW0 9/20 0.72
LPAR1 Q92633 6/20 0.72
LPAR5 Q9H1C0 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phosphoric Acid Monododecyl Ester SCHEMBL30724148 1.00 LPAR3 (0.72) LPAR3LPAR2LPAR1LPAR5
Trolamine SCHEMBL10437940 1.00 LPAR3 (0.72) LPAR3LPAR2LPAR1LPAR5
Phosphoric Acid Monotetradecyl Ester SCHEMBL9184936 1.00 LPAR3 (0.72) LPAR3LPAR2LPAR1LPAR5
Trolamine SCHEMBL10437955 1.00 LPAR3 (0.72) LPAR3LPAR2LPAR1LPAR5
Trolamine SCHEMBL10437956 1.00 LPAR3 (0.72) LPAR3LPAR2LPAR1LPAR5
Trolamine SCHEMBL11209409 1.00 LPAR3 (0.72) LPAR3LPAR2LPAR1LPAR5
Phosphoric Acid Monotetradecyl Ester SCHEMBL4926609 1.00 LPAR3 (0.72) LPAR3LPAR2LPAR1LPAR5
Phosphoric Acid Monododecyl Ester SCHEMBL322337 1.00 LPAR3 (0.72) LPAR3LPAR2LPAR1LPAR5
Hexadecyl Dihydrogen Phosphate SCHEMBL9302969 1.00 LPAR3 (0.72) LPAR3LPAR2LPAR1LPAR5
Phosphoric Acid Monodecyl Ester SCHEMBL10438564 1.00 LPAR3 (0.72) LPAR3LPAR2LPAR1LPAR5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-5009495-A None JP disclosed
US-8513174-B2 Cleanser SHISEIDO COMPANY LTD. (JP) 2013-08-20 US disclosed
EP-2251403-B1 CLEANSING COMPOSITION SHISEIDO CO LTD (JP) 2012-08-29 EP disclosed
US-20100317555-A1 Cleanser SHISEIDO COMPANY LTD. (JP) 2010-12-16 US disclosed
EP-2251403-A1 CLEANSING COMPOSITION Shiseido Company, Ltd. (JP) 2010-11-17 EP disclosed
US-6066674-A BIGUANIDE GERMICIDE, METAL CHELATING AGENT, AND ANIONIC SURFACTANT IN GIVEN WEIGHT PERCENTS; CLEANING SURFACES KAO CORPORATION (JP) 2000-05-23 US disclosed
EP-0442701-B1 Topical composition UNILEVER PLC (GB) 1996-04-24 EP disclosed
EP-0324451-B1 Use of a detergent composition comprising a mixture of a phosphate-type and an alkyl saccharide-type surface active agents as a shampoo, skin cleanser or fine fabric detergent KAO CORP (JP) 1995-09-13 EP disclosed
EP-0324575-B1 Detergent composition KAO CORP (JP) 1994-10-12 EP disclosed
JP-H059495-A CLEANING AGENT COMPOSITION KAO CORP 1993-01-19 JP disclosed
US-5120464-A DETERGENT COMPOSITION KAO CORPORATION (JP) 1992-06-09 US disclosed
US-5062989-A DETERGENT COMPOSITION KAO CORPORATION (JP) 1991-11-05 US disclosed
EP-0371803-A1 Topical composition UNILEVER PLC (GB) 1990-06-06 EP disclosed
EP-0324575-A2 Detergent composition Kao Corporation (JP) 1989-07-19 EP disclosed
EP-0324451-A1 Use of a detergent composition comprising a mixture of a phosphate-type and an alkyl saccharide-type surface active agents as a shampoo, skin cleanser or fine fabric detergent Kao Corporation (JP) 1989-07-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100317555-A1 Cleanser STS, SGMS1, PTDSS1 LPAR3 1373/4885LPAR2 1267/4885LPAR1 1179/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.